A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants
Clinical trial NCT05630274 · COMPLETED
Trial details
- NCT number
- NCT05630274
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2019-06-21
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.